Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Food

DSM-Firmenich slows down vitamin production

by Matt Blois
July 1, 2023 | A version of this story appeared in Volume 101, Issue 21

Responding to high input costs and low selling prices for vitamins, DSM-Firmenich, formed when DSM and Firmenich completed a merger in May, is reducing production of some vitamins for livestock. The company’s animal health business will put more focus on data analytics to improve sustainability and animal health, as well as on products such as probiotics, enzymes, and mycotoxin deactivators. DSM-Firmenich has already shut down a vitamin C plant in China and plans to close a vitamin B6 plant there as well. Production of vitamins A and E will be paused at Swiss plants later this year. The firm hopes the changes will save $218 million annually by 2024. Separately, DSM says it won’t reopen a perfume and beauty ingredient plant in Brunswick, Georgia, that was damaged by a fire in April.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.